Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
August 31, 2023 08:00 ET
|
Aspira Women's Health Inc.
Samples to be used in validating the Company’s EndoCheckSM test in development for the diagnosis of endometriosis AUSTIN, Texas, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc....
Aspira Women’s Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 29, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health...
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
August 28, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc.(“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health diagnostic...
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
Aspira Women's Health Inc.
Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022. OvaSuiteSM volume of 6,289 units, an increase of 16% year-over-year ...
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
August 09, 2023 16:05 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
July 31, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, July 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic...
Aspira Women’s Health Announces $4.7 Million Registered Direct Offering
July 20, 2023 08:30 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, July 20, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD
June 28, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, June 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health Appoints Dr. Winfred Parnell to its Board of Directors
June 05, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease...
Aspira Women’s Health Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
June 02, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, June 02, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease...